- AdventHealth
On Aug. 3, Barry Friedman, executive director of the AdventHealth Transplant Institute addressed the U.S. Senate Committee on Finance, along with other senators and health care leaders, to shed light on the failures of the United Network for Organ Sharing (UNOS), a nonprofit that manages the country’s organ transplants.
AdventHealth leader Barry Friedman testifies in front of the U.S. Senate Finance Committee on August 3, 2022
“This system has failed many patients waiting for organ transplant due to lack of oversight and accountability,” Friedman said during his testimony.
As a transplant surgeon specializing in kidney and pancreas transplant and laparoscopic surgeries, Bobby Nibhanupudy, M.D., agrees there are gaps in the system that must be addressed. Nibhanupudy serves as the medical director of abdominal transplant at the AdventHealth Transplant Institute and OurLegacy, the region’s organ procurement agency, and has first-hand experience with the inequities. To his frustration, organs from donors have frequently been repeatedly lost or damaged.
Nibhanupudy highlighted one problem – transportation. Private transportation is arranged for organs with a shorter shelf-life, but for kidneys, commercial airlines are typically used to transport the kidney to the recipient.
Kidneys make up about 75% of AdventHealth’s total transplants and Nibhanupudy says there is currently no standard way to track these organs.
“In many cases, organs must connect from one flight to another, leaving airline personnel responsible for (airline) transfers,” said Friedman. “While anyone can track their Amazon or FedEx package, there is currently no consistent way of tracking these life-saving organs.”
“We hear stories all the time of organs that don’t end up where they’re supposed to be, which could lead to a preventable death somewhere down the line,” said Nibhanupudy. “In one case, we sent an organ to California, and it wound up staying in the middle of the country because of a missed connection.”
Nationwide, approximately 23% of kidneys procured from deceased donors are not used and discarded, resulting in preventable deaths, according to the American Society of Nephrology and Organ Procurement Transplantation Network (OPTN).
This lack of standardized technology to track organs mirrors Friedman’s comments to the Senate, along with questioning the change in the new UNOS system. Under the previous allocation system, transplant waiting lists were maintained regionally, but now they are based on 250- to 500-mile radiuses and, in the case of kidneys, prioritize those on dialysis longer.
According to Nibhanupudy, these criteria can be flawed.
“Somebody who has been on dialysis for five years isn’t necessarily sicker than somebody who’s been on dialysis for two years,” said Nibhanupudy. “The new allocation system pulls kidneys away from mid-sized cities and states, like our mid-sized city, to higher populated cities just because they have a higher number of individuals who are on dialysis, which means their waitlists are bigger.”
On average, 22 people die each day, roughly one per hour, waiting for a life-saving organ transplant.
Since its inception in 1973, the AdventHealth Transplant Institute has performed more than 4,700 kidney transplants and more than 6,300 organ transplants, and the hospital could have performed more if not for the failures of the new organ allocation rules.
The AdventHealth Transplant Institute is the only adult and pediatric organ transplant program in Central Florida and one of only 63 programs in the U.S. that performs multi organ transplants. The transplant institute is a part of AdventHealth Orlando, recently ranked the No. 1 hospital in Central Florida by U.S. News & World Report and No. 2 in Florida.
To read more about the failed organ transplant system in a recent Washington Post article, click here. For more how the program has failed patients, read a recent Orlando Sentinel story featuring Nibhanupudy here.
Recent News
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
AdventHealth East Orlando recently became the first hospital in Florida to earn Advanced Foot & Ankle Surgery Certification from DNV, a worldwide, independent certification body.